Article
[24 weeks treatment with pegylated interferon alfa plus ribavirin may be possible in genotype 1 chronic hepatitis C patients with rapid virological response who have low pretreatment viremia].
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi - 1 Jul 2010
Moon Sung Soo, Kang Hyoun Gu, Seo Jeong Ah, Jung Eun Uk, Lee Sang Heon, Park Sung Jae, Lee Youn Jae, Seol Sang Yong
Abstract excerpt
BACKGROUND/AIMS: The standard treatment for chronic hepatitis C infected with hepatitis C virus (HCV) genotype 1 is a combination of pegylated interferon alfa and ribavirin over a 48 weeks period. It is unclear if 24 weeks treatment is possible for patients showing a rapid virological response (RVR) without compromising the sustained virological response (SVR) in Korea. METHODS: Between June 2005 and September...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
